|
Apr 24
|
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
|
|
Apr 11
|
Investors in Coherus BioSciences (NASDAQ:CHRS) have unfortunately lost 83% over the last five years
|
|
Apr 8
|
Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting
|
|
Mar 16
|
Coherus BioSciences, Inc. (NASDAQ:CHRS) Q4 2023 Earnings Call Transcript
|
|
Mar 15
|
Coherus BioSciences Full Year 2023 Earnings: EPS Misses Expectations
|
|
Mar 14
|
Why Coherus Biosciences Stock Tumbled on Thursday
|
|
Mar 14
|
Q4 2023 Coherus BioSciences Inc Earnings Call
|
|
Mar 13
|
Coherus BioSciences Inc (CHRS) Reports Growth in Net Revenue for Q4 and Full Year 2023 Despite ...
|
|
Mar 13
|
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
|
|
Mar 6
|
In the wake of Coherus BioSciences, Inc.'s (NASDAQ:CHRS) latest US$49m market cap drop, institutional owners may be forced to take severe actions
|
|
Mar 5
|
Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024
|
|
Mar 4
|
Coherus Completes Divestiture of Ophthalmology Franchise
|
|
Jan 25
|
Analysts Are More Bearish On Coherus BioSciences, Inc. (NASDAQ:CHRS) Than They Used To Be
|
|
Jan 12
|
Here’s Why Aristotle Small Cap Equity Strategy Sold Coherus BioSciences (CHRS)
|
|
Dec 24
|
2 Small Cap Stocks That Could Go Parabolic in 2024, According to Wall Street
|
|
Dec 22
|
Coherus BioSciences Announces New Employment Inducement Grants
|
|
Dec 7
|
Coherus BioSciences Announces CFO Transition Plans
|
|
Dec 6
|
Coherus Presents Phase 1/2 Clinical Data on Casdozokitug, a First-in-Class IL-27-Targeted Antibody, at the 2023 ESMO Immuno-Oncology Congress
|
|
Nov 28
|
Coherus and Junshi Biosciences Announce Publication of Positive Final Overall Survival Results of JUPITER-02, a Phase 3 Trial Evaluating LOQTORZI™ (toripalimab-tpzi) as Treatment for Nasopharyngeal Carcinoma, in the Journal of the American Medical Asso...
|
|
Nov 7
|
Why Coherus Biosciences Stock Dropped Today
|